Catalyst

Slingshot members are tracking this event:

Apitegromab Phase 3 sapphire results

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
SRRK

100%

Additional Information

Management Comment We look forward to reporting the topline results from this registrational study in Q4 next year
https://investors.sc...
Slingshot Insights Explained
Catalyst Date
Future Window:
Oct 01, 2024 - Dec 31, 2024
Related Keywords Srk-015, Apitegromab, Spinal Muscular Atrophy, Myostatin, Test Alerts